STI571 in Treating Patients With Recurrent Leukemia
NCT00004932
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
31
Enrollment
NETWORK
Sponsor class
Conditions
Leukemia
Interventions
DRUG:
imatinib mesylate
Sponsor
Children's Oncology Group
Collaborators
[object Object]